Daxx was originally isolated as a Fas-binding protein. However, the in vivo function of Daxx in Fas-induced apoptosis has remained enigmatic. Fas plays an important role in homeostasis in the immune system. Fas gene mutations lead to autoimmune-lymphoproliferation (lpr) diseases characterized by hyperplasia of secondary lymphoid organs. It is well established that the FADD adaptor binds to Fas, and recruits/activates caspase 8. However, additional proteins including Daxx have also been indicated to associate with Fas. It was proposed that Daxx mediates a parallel apoptotic pathway that is independent of FADD and caspase 8, but signals through ASK1-mediated apoptotic pathway. However, because the deletion of Daxx leads to embryonic lethality, the in vivo function of Daxx has not been properly analyzed. In the current study, analysis was performed using a conditional mutant mouse in which Daxx was deleted specifically in T cells. The data show that Daxx-/- T cells were able to undergo normal Fas-induced apoptosis. While containing normal thymocyte populations, the T cell-specific Daxx-/- mice have a reduced peripheral T cell pool. Importantly, Daxx-deficient T cells displayed increased death responses upon activation through TCR stimulation. These results unequivocally demonstrated that Daxx does not mediate Fas-induced apoptosis, but rather that it plays a critical role in survival responses in primary mature T cells.
Citation: Li J, Qian L, Dowling JP, Curcione C, Kurup D, Zhang J (2017) Daxx plays a novel role in T cell survival but is dispensable in Fas-induced apoptosis. PLoS ONE 12(3): e0174011. https://doi.org/10.1371/journal.pone.0174011
Editor: Pierre Bobé, Universite Paris-Sud, FRANCE
Received: July 7, 2016; Accepted: March 1, 2017; Published: March 16, 2017
Copyright: © 2017 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are contained within the paper.
Funding: This study is supported in part by NIH grants R21 AI105794 and R01 AI119069 to J.Z. The Flow Cytometry Facility and Research Animal Facility of the Sidney Kimmel Cancer Center, where some of the analysis was performed, is supported in part by NCI Cancer Center support grant P30CA56036.
Competing interests: The authors have declared that no competing interests exist.
Programmed cell death through apoptosis plays a critical role in the immune system. One of the major apoptotic signaling pathways is mediated by Fas (Apo-1 or CD95), a single transmembrane-domain protein of the neural growth factor receptor (NGFR)/tumor necrosis factor receptor (TNFR) super-family . Basal level expression of Fas is detected in many tissues . However, high levels of Fas are expressed in immature thymocytes and peripheral mature T cells. Fas is further induced upon activation of mature T cells [3,4].
Fas was originally identified as a cell surface antigen recognized by a monoclonal antibody which has a cytocidal effect on various tumor cells and primary cells [5,6]. The importance of Fas was first appreciated from the studies of a mutant mouse line which develops age-dependent lymphoproliferative (lpr) diseases manifesting lymphadenopathy and splenomegaly due to progressive accumulation of a peculiar T cell population which down-regulates the CD4 and CD8 co-receptors but expresses B220, a B cell-specific marker . The lpr mice develop autoimmune diseases such as arthritis and symptoms similar to system lupus erythematosus (SLE), including high levels of autoantibodies. Studies mapped the Fas gene to the lpr locus and showed that the lpr mice carry mutant Fas alleles . Importantly, targeted disruption of Fas led to lpr diseases, while transgenic expression of wild type Fas in lymphocytes corrected the phenotype in the naturally occurring Fas mutant mice [9,10].
The intracellular sequence of Fas contains a functional module called the death domain (DD) which is essential for apoptotic signaling [11,12]. When engaged to Fas ligand (FasL), Fas recruits the adaptor protein FADD (Fas-associated death domain or Mort1) through homotypic interactions between the two death domains [13–15]. FADD contains a second protein-protein interaction motif, the death effector domain (DED), which binds to the DED in pro-caspase 8 [16,17]. Once activated, the initiator caspase 8 cleaves and activates downstream effector caspases 3 and 7, leading to apoptosis [18,19].
In addition to FADD, other proteins such as Daxx were also identified as a potential Fas-interacting protein in yeast cells . In mammalian cells, Daxx presumably binds to a region in the Fas death domain that is distinct from where FADD binds [20–22]. The interaction between the endogenous Fas-FADD is readily induced upon stimulation of Fas and can be detectable by conventional co-immunoprecipitation assays [13,23]. While overexpressed Daxx and Fas may be found in a complex, detecting the interaction of the endogenous Daxx and Fas has proved to be a challenge [20–22]. Daxx may also interact with cellular FLICE-like inhibitor protein long form (cFLIPL) , which is an enzyme-dead homologue of caspase 8 and plays an inhibitory role in Fas-induced apoptosis . Furthermore, besides Fas signaling, Daxx may also be involved in TGF-β-induced apoptosis . Unlike FADD, Daxx does not contain a DD or DED, and therefore it does not recruit caspase 8. Instead, it has been suggested that Daxx mediates Fas- and TGF-β-induced cell death through Ask1-Jnk activation [22,26]. However, some evidence also indicates that Fas activates Jnk independently of Daxx [26,27].
An earlier study of Daxx was performed by overexpressing a dominant-negative mutant, Daxx-DN, in cell lines, which concluded that Daxx was not involved in Fas-induced apoptosis . However, a subsequent study indicated that Daxx-DN inhibited Fas-induced apoptosis in primary T cells . Therefore, whether Daxx plays a role in the Fas-signaling pathway has remained an unresolved issue. Interestingly, the embryonic defects in Daxx knockout mouse did not appear to be due to lack of apoptosis as anticipated. Rather, massive apoptotic death was observed in Daxx-/- embryos at day 8–9 of gestation . In the current study, we employed conditional mutant mice in which Daxx was specifically deleted in T lineage cells in order to understand the physiological function of Daxx. Our data revealed a novel, temporal requirement for Daxx in peripheral mature T cells.
Materials and methods
Mice are housed in AAALAC-accredited vivarium at Thomas Jefferson University, and kept on autoclaved water and diet 5010 (LabDiet, St. Louis, MO) in ventilated racks. Nestlets were provided as enrichment. Cages get changed once every two weeks. The physical condition of mice was monitored at least once daily. A protocol is in place for the early euthanasia/humane endpoints for animals that became severely ill/moribund during the experiments. If mice were severely ill/moribund, displaying dramatic weight loss, rough hair/hunched back, and movement difficulties, euthanasia would be performed by CO2 inhalation. There was no illness or death prior to experimental endpoint. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee (IACUC) of the Thomas Jefferson University.
LckCre transgenic mice were described previously  and were originally obtained from Taconic and maintained on-site. Mice carrying the conditional knockout allele of Daxx (Daxxf/f) were created in Dr. P. Leder’s laboratory (Harvard Medical School). To generate T-cell specific Daxx-deficient mice, Daxxf/f mice were crossed with LckCre transgenic mice. The resulting heterozygous Daxx+/f LckCre mice were intercrossed to obtain T cell-specific Daxx-deficient, Daxxf/f LckCre mice which were subsequently crossed with Daxxf/f mice to produce Daxxf/f LckCre (50%) mutant and Daxxf/f (50%) control mice. To determine the genotypes, genomic DNA was extracted from the mouse tail, and used as templates for PCR amplification using allele-specific primers. Wild type and conditional knockout Daxx alleles were typed with primers 5’–AGCAGTAACTCCGGTAGTAGGAAG-3’ and 5’-AGGAACGGAACCACCTCAG-3’. The LckCre transgene was typed by PCR using primers 5’-CCGAAATTGCCAGGATCAGG-3’ and 5’-CTTACCTGTAGCCATTGCAGCTAG -3’. Mice are housed in an on-site facility and all procedures using mice were approved by the institutional animal care and use committee (IACUC) at Thomas Jefferson University.
Western blotting analysis
Mice were euthanized and the indicated non-lymphoid organs or tissues were homogenized in RIPA lysis buffer containing 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, 2 mM EDTA, 50 mM NaF, and a proteinase cocktail (Roche), followed by incubation on ice for 30 min. The spleen and lymph nodes were harvested, and single cell suspensions were prepared from these lymphoid organs. After red blood cell depletion by hypotonic lysis using ACK buffer, cells were enumerated using a Countess® Automated Cell Counter (Invitrogen). Peripheral mature T cells were isolated by sorting for the Thy1.2+ population from total splenocytes and lymph node cells. These purified T cells were either left untreated or stimulated with plate-bound anti-CD3 Abs (1 μg/ml) plus soluble anti-CD28 Abs (1 μg/ml) for the indicated times. Resting or activated T cells were lysed in RIPA buffer or 1% Triton lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 20 mM EDTA and a proteinase cocktail) on ice for 30 min. Cell debris was removed by centrifugation at 14000 g for 5 min at 4°C. Total protein concentrations of the resulting lysates were determined using a Bio-Rad reagent (Cat#500–0006). Proteins (40 μg) were resolved by 10% or 15% PAGE, and western blotting performed using anti-Daxx and anti-p53 antibodies (Santa Cruz Biotechnology).
Flow cytometric analysis of lymphocytes
For flow cytometric analysis, cells (~106) from the indicated lymphoid organs were stained on ice for 30 min in 100 μl PBS containing 3% BSA, 1 mM EDTA, and 0.05% NaN3 with appropriate fluorochrome-conjugated antibodies against CD3, CD4, CD8, and B220. Data acquisition was performed using a Coulter Epics XL (Beckman Coulter) or a LSR II (Becton Dickinson) flow cytometer, and analyzed with the Flowjo software (Treestar). T cell numbers were estimated based on total cellularity and percentages of the CD3+ population in organs as indicated. Unpaired two-tailed t-tests were performed to obtain the p values, for comparison of total cellularity as well as total T cell numbers in mutant and control mice.
T cell death assay
Total thymocytes were seeded into 96-well flat bottom plates (105/well) in complete RPMI (10% FBS) and incubated at 37°C without additional stimulation for the indicated times, or with various concentrations of the Jo2 monoclonal anti-mouse Fas antibody (BD Pharmingen) plus cycloheximide (30 μg/ml; Sigma-Aldrich) for 14 h. Thymocytes were treated with the indicated concentrations of etoposide (Sigma-Aldrich) for 14 h at 37°C as described . Mature T cells were isolated from the spleen and lymph nodes using the EasySep mouse T cell purification reagents (StemCell Technology), and stimulated with anti-CD3 ascites (1:1000 dilution) plus anti-CD28 ascites (1:1000 dilution) in round-bottom 96-well plates (105/well). After incubating for 2 days at 37°C, these T cells were washed twice with PBS, and cultured in complete RPMI plus IL-2 (400 U/ml, NCI) for two days. The resulting activated T cells were treated with the indicated concentrations of soluble anti-Fas antibody or in wells coated with the indicated concentrations of anti-CD3 antibodies (2C11; BD Pharmingen) in flat-bottom 96-well plates (2 x 104 /well). After incubation at 37°C for 16 h, T cells were stained with propidium iodide (PI, 1 μg/ml) and analyzed using a flow cytometer as described previously . Death is indicated by percent of PI+ cells. Additionally, T cells were stained with annexin V-FITC and PI with a FITC Annexin V Apoptosis Detection Kit I (BD 556547), and two color flow cyometric analysis performed.
At the indicated times post stimulation with anti-CD3/CD28 ascites, cell cycle profiles were analyzed by determining DNA contents as previously described . Briefly, cells were washed once with PBS containing 1% BSA and 0.01% NaN3, dispersed in 100 μl of a staining solution (0.1% sodium citrate, 0.1% Triton X-100, 50 μg/ml propidium iodide, 100 μg/ml RNaseA), and subsequently analyzed using a Coulter Epics XL or FACSCalibur flow cytometer.
T cell proliferation assays
Mature T cells purified from the spleen and lymph nodes (105) were seeded into 96-well round bottom plates in 100 μL of complete RPMI. After addition of anti-CD3 ascites at various dilutions and anti-CD28 ascites (1:1000 dilution), cells were incubated for 40 h at 37°C, followed by an 8 h pulse with 0.5 μCi of [3H] thymidine. Cells were collected using a 96-well harvester, and thymidine incorporation was determined by using a liquid scintillation counter. T cell accumulations were determined by enumeration using a hemocytometer, and proliferation was shown as bar graphs or growth curves. T cell division kinetics were analyzed using the CellTrace™ Violet Cell Proliferation Kit (Invitrogen), as per the manufacturer’s instruction. Briefly, 2μl of Cell Trace Violet (5 mM) in DMSO was added to 2 ml of purified T cells (106/ml) in 2 ml PBS. After 20 min incubation at 37°C, the reaction was quenched by adding 10 ml complete RPMI 1640, followed by 5 min incubation at 37°C. After centrifugation, the labeled T cells were resuspended in 1 ml complete RPMI, and were seeded into wells (2×105 cells/well) of 96-well round-bottom plates. Stimulation of T cells was initiated by adding anti-CD3 and anti-CD28 ascites (1:1000 dilution). Alternatively, 96-well flat-bottom plates were coated with anti-CD3 antibodies (1 μg/ml; BD Pharmingen 553058) for 2 h, and the labeled T cells were then seeded to each well. Anti-CD28 was added into each well at the concentration of 1 μg/ml (BD Pharmingen 553294). After incubation at 37°C for the indicated time, T cells were analyzed using a LSR II flow cytometer. Dead cells were detected by staining with propidium iodide (PI, 1 μg/ml).
Caspase activity measurement
Caspase activity was determined using CellEvent Caspase-3/7 Green Flow Cytometry Assay Kit (Invitrogen), as per the manufacturer’s instruction. Mature T cells purified from the spleen and lymph nodes (105) were seeded in 100 μL of complete RPMI into 96-well round bottom plates coated with anti-CD3 abs (1 μg/ml; BD Pharmingen 553058) for 2 h. Anti-CD28 abs (0.2 μg/ml; BD BioSciences 553294) were added into each well. After incubation at 37°C for the indicated time, CellEvent Caspase-3/7 Green Detection Reagent (400 nM) was then added into T cell suspensions for 30 min at 37°C and analyzed using an LSR II flow cytometer.
T cell adoptive transfer
B6.CD45.1+ mice were obtained from The Jackson Laboratory and subjected to a 500rad irradiation. Daxx+/+ and Daxx-/- donor T cells (CD45.2+) were isolated from the spleen and lymph nodes of indicated mice. T cells were resuspended in PBS and adoptively transferred into irradiated CD45.1+ recipient mice (3 x 106 cells/mouse) by retroorbital injection. Seven days later, spleen and lymph nodes of recipient mice were made into single cell suspensions, stained with anti-CD45.1+ and CD45.2+ (eBioscience) and anti-Thy1.2 (BD Biosciences) antibodies, and analyzed by flow cytometry on an LSR II.
Tissue expression and conditional deletion of Daxx in T cells
Since the initial cloning of Daxx as a potential Fas-interacting protein , its function in Fas-induced apoptosis has remained enigmatic [27,29]. Deletion of Daxx in germ cells leads to early embryonic lethality , which has prevented further analysis of the function of Daxx in the adult immune system. We performed western blot analysis to determine the expression of the Daxx protein in various tissues. Interestingly, we found that Daxx is not widely expressed in adult mice (Fig 1A). High levels of the Daxx protein were detected in the testis and thymus, and lower levels were detected in the spleen. Other tissues tested contain minimal levels of Daxx (Fig 1A). We performed a further analysis, using western blotting with mature T cells purified from the peripheral lymphoid organs. As shown in Fig 1B (Left panel), the Daxx protein is highly expressed in peripheral mature T cells, similar to that in thymocytes.
(A) The Daxx protein levels in the indicated organs of wild type adult mice were analyzed by western blotting. (B) To detect Daxx expression in T cells, total thymocytes or mature T cells sorted from the spleen and lymph nodes were prepared. Mature T cells were stimulated with anti-CD3 and CD28 antibodies for the indicated times (Activated T). Western blotting analysis was performed using antibodies against mouse Daxx. Fold changes were indicated below each blot. Ponceau S staining was performed as protein loading and transfer control (A). β-actin was used as blotting control (B). Total cell numbers in the indicated lymphoid organs (C), and T cell numbers (D) from the indicated organs of mutant mice (filled circles) and control mice (open circles) were shown. *** indicates p values < 0.05.
The apparently restricted tissue expression of Daxx prompted us to examine its physiological function in primary T cells, where Daxx is highly expressed (Fig 1A and 1B). Given the embryonic lethality in Daxx-/- mice shown in the previous study , we performed lineage-specific deletion of Daxx using a conditional knockout mice (Daxxf/f), in which exon 2 of Daxx is flanked with two loxP sites. To induce T cell-specific deletion of Daxx, the Daxxf/f mice were crossed with mice containing the T cell-specific LckCre transgene . The expression of LckCre is initiated in pro/pre T cells as previously described [30,32]. Western blotting was performed to detect Daxx in the resulting mutant Daxxf/f LckCre mice, using Daxxf/f litter mates as a control which expresses Daxx at levels similar to Daxx+/+ wild type mice (data not shown). Deletion of the Daxx gene was evident, since the levels of the Daxx protein were dramatically reduced in thymocytes and purified mature T cells from Daxxf/f LckCre mice compared to control Daxxf/f mice (Left panel, Fig 1B). Peripheral mature T cells isolated from the spleen and lymph nodes were stimulated with anti-CD3 and anti-CD28 antibodies, and the resulting activated T cells from mutant Daxxf/f LckCre mice contained minimal levels of the Daxx protein compared to T cells from control Daxxf/f mice (Right panel, Fig 1B). Therefore, LckCre induced efficient deletion of Daxx in T cells. Hereafter, Daxxf/f LckCre mice are also referred to as Daxxt-/- mice.
Daxx deletion does not lead to progressive accumulation of peripheral T cells, unlike the lpr symptom seen in Fas-deficient mice
To evaluate the impact of T cell-specific Daxx deficiency in the lymphoid compartment, the thymus, spleen, and lymph nodes were isolated from Daxxt-/- mutants and total cell numbers in these organs were determined. As shown in Fig 1C, there was no significant difference in the thymic cellularity between Daxxt-/- mutant and control mice. However, the total cell numbers in the lymph nodes and spleen appeared to be reduced significantly in Daxxt-/- mutant mice, as compared to control mice (Fig 1C). Flow cytometry was performed to analyze the T lineage through staining for the T cell marker CD3, and the B cell marker, B220. CD3+ T cells were present in Daxxt-/- mutant mice, although the percentages in the spleen and lymph nodes were lower compared to control mice (Fig 2A). The absolute T cell numbers in the lymph nodes and spleen of Daxxt-/- mutant mice were lower than that of control mice (Fig 1D). Further flow cytometric analysis of T cell subsets was performed, revealing that the thymic T cell profile of Daxxt-/- mutant mice, including the proportions of pro/pre T cells (CD4-CD8-), immature T cells (CD4+CD8+), and mature T cells (CD4+ or CD8+), is similar to that found in control Daxx+/+ mice (Fig 2B, top panel). However, the percentages of both the CD4+ and CD8+ T cell lineages in the peripheral lymphoid organs, including the spleen and lymph nodes, were lower in Daxxt-/- mutant mice than in control mice (Fig 2B). This finding agrees with the observation showing a decrease in the total peripheral T cell numbers in mutant mice compared to control mice (Fig 1D). The CD4 and CD8 T cell profiles were analyzed by gating on the CD3+B220- population, and the data indicated no effect on CD4 or CD8 expression in T cells (Fig 2C). There was no phenotypic difference among Daxx+/+, Daxxf/f, and Daxx+/+ LckCre control mice. Therefore, they were used as the wild type control hereafter and the Daxx+/+ controls include mice of all three genotypes.
Cells were isolated from the thymus, spleen, and lymph nodes in mutant Daxxt-/- and Daxx+/+ control mice, stained for CD3 and B220 (A), or CD4, CD8, CD3, and B220 (B and C) and flow cytometric analysis was performed. Percentages represent the fraction of each indicated subpopulation of the lymphocytes gate. CD4 and CD8 expression was analyzed by gating on the CD3+B220- population (C). Data are representative of at least 6 independent experiments.
Normal Fas-induced apoptotic responses in Daxx-deficient T cells
While Fas is widely expressed, its absence leads to pathology mostly restricted to the lymphoid system, without affecting mouse embryonic or postnatal development. Interestingly, although Daxx was originally identified as a possible mediator of Fas-induced apoptosis , Daxx-/- mice die at an early embryonic stage due to massive death in various tissues, as shown previously . To determine the effect of Daxx deficiency on death responses, T cells were isolated from the thymus, spleen or lymph nodes of Daxxt-/- mutant and Daxx+/+ control mice and cultured in medium without additional stimulation. The percentages of viable cells at various times in Daxx-/- thymocytes or peripheral mature T cell cultures were comparable to those in control Daxx+/+ T cells (Fig 3A and 3B). Therefore, deletion of Daxx does not alter ex vivo survival of T cells. We then analyzed T cell responses to Fas stimulation. Wild type thymic immature T cells readily undergo apoptosis when stimulated through Fas, and this response did not appear to be affected by Daxx deficiency (Fig 3C). Intrinsic death responses in Daxx-/- T cells induced through treatment with etoposide were not impacted either (Fig 3D). Repeated stimulation through the TCR lead to apoptotic death that is mediated by Fas, a process referred to as activation-induced cell death (AICD) [34–36]. To determine whether Daxx plays a role in AICD, T cells were activated through challenges with anti-CD3 antibodies to crosslink the TCR, and then cultured in the presence of IL-2. The resulting activated T cells were treated with soluble anti-Fas antibodies or plate-bound anti-CD3 antibodies, and cell death was determined. We found that Daxx-/- mutant and Daxx+/+ control T cells were both sensitive to killing by stimulation with anti-Fas antibodies or re-stimulation of the TCR with anti-CD3 antibodies (Fig 3E and 3F). Taken together, these results indicate that Daxx does not play a role in Fas-induced apoptosis or TCR activation-induced cell death (AICD) in T cells.
Thymocytes (A) or purified mature T cells (B) were cultured in complete medium without additional stimulation and viability was determined at the indicated times after incubation at 37°C. Thymocytes were treated with the indicated concentrations of anti-Fas antibodies (C) or etoposide (D) for 14 h. Mature T cells were stimulated with anti-CD3/CD28 antibodies and the resulting activated T cells were treated with anti-Fas (E) or anti-CD3 (F) antibodies for 16 h. T cells were stained with PI, and percentages (mean ± SEM of triplicates) of cell death (PI+) were determined using a flow cytometer. Data represents 3 independent experiments.
Proliferative and death responses in activated Daxx-/- T cells
To analyze the effect of Daxx deletion on T cell proliferative responses, spleen and lymph node cells were isolated from Daxxt-/- and control Daxx+/+ littermates. T cells were purified and stimulated through the TCR and the co-stimulatory receptor CD28 with the corresponding agonistic antibodies. Relative T cell proliferation was determined by the amount of incorporation of [3H] thymidine into the DNA of T cells. Daxx-/- mutant and Daxx+/+ control T cells appeared to proliferate similarly at 48 h post stimulation (Fig 4A). To further analyze T cell proliferation responses, we performed analyzed cell division kinetics by labeling purified T cells with the CellTrace Violet™ fluorescent dye and then stimulating them with agonistic anti-CD3 and anti-CD28 Abs. The dye is diluted as T cells divide, and the T cells undergoing cell divisions can be detected as distinct populations of decreasing intensities of CellTrace Violet fluorescence using a flow cytometer. As shown in Fig 4B, upon activation through TCR stimulation, divided cell populations were detected in Daxx-/- mutant T cells (48.3% at 36 h and 79.8% at 48 h) and in Daxx+/+ T cells (34.6% at 36 h and 73.8% at 48 h). These results indicate that when Daxx is absent, T cells are able to undergo cell division induced by TCR signaling. It appears that mutant T cells divide more readily than control T cells (see also below).
(A), Mature T cells purified from the spleen and lymph nodes in mice of the indicated genotypes were stimulated with anti-CD3/CD28 antibodies at the indicated dilutions (x-axis) for 48 h and proliferation was determined based on the amounts of tritiated thymidine (cpm) incorporated into activated T cells. Error bars indicate SEM of triplicates of one experiment, representing at least three independent experiments. (B), Mature T cells were labeled with CellTrace Violet™, stimulated with anti-CD3/CD28 antibodies for the indicated times, and analyzed using a flow cytometer. Percentages of divided cells are shown. Data represents 3 independent experiments. (C), Mature T cells were purified, stimulated with anti-CD3/CD28 antibodies as indicated in (A-B). DNA content was determined by PI staining and flow cytometry. Numbers indicate the percentages of cells in each cell cycle stage. (D), Mature T cells were labeled with CellTrace violet and activated as in (B) for the indicated times, stained with PI and analyzed by two-color flow cytometry. Percentages of undivided (CellTrace Violet+PI-) and divided cells (CellTrace VioletloPI-) and cell death (PI+) are indicated. (E), Cell numbers at the indicated times following T cell activation were enumerated and growth curves plotted (mean ±SEM; n = 3).
In further analysis, we determined whether Daxx deficiency affected cell cycle progression. Purified T cells were stimulated with anti-CD3 and anti-CD28 antibodies, and the DNA content of activated T cells was analyzed by staining with propidium iodide. The percentage of cells at various cell cycle stages was determined by measuring the relative DNA content in the cells, as indicated by PI fluorescence using a flow cytometer. The percentages of cells in the G0/1, S and G2/M phase tend to be lower in mutant Daxx-/- T cells than in control Daxx+/+ T cells (Fig 4C). Importantly, mutant Daxx-/- T cells consistently had higher percentages of cells in the sub-G0/1 phase than the control Daxx+/+ T cells (Fig 4C). The sub-G0/1 phase population typically represents dying cells.
To analyze cell death responses versus proliferative responses further, we performed two color flow cytometry analysis. We used the CellTrace dye to label T cells and then activated them with anti-CD3 and -CD28 antibodies. Cell death was measured using propidium iodide (PI) uptake. There were fewer undivided cells in the Daxx-/-mutant (13.8%) than in the control (41.2%) at 48 h post stimulation (Fig 4D). Concomitantly, Daxx-/- mutant T cells had more divisions than in Daxx+/+ control T cells (24.6% vs. 20.8%). These differences became more apparent at 72 h post TCR stimulation, where 4.6% of mutant T cells were undivided, a percentage much lower than the 25.2% of undivided control T cells. At this later time point, more division occurred in the mutant than in the control T cells (50.7% vs. 45.5%). Importantly, more cell death (53.9% at 48 h and 40.2% at 72 h) was observed in mutant than in control T cells (30.6% at 48 h and 25.5% at 72 h, Fig 4D). Finally, the numbers of activated T cells were determined and growth curves were generated, which indicate lower accumulation of Daxx-/- mutant T cells than Daxx+/+ control T cells (Fig 4E). In total, a lack of Daxx consistently results in enhanced death responses in T cells (Fig 4C, 4D and 4E).
Lack of Daxx leads to enhanced apoptosis in Daxx-/- T cells
To understand the mechanism of the enhanced cell death response in Daxx-/- T cells, caspase activity was measured through CellEvent Caspase-3/7 Green Detection Reagent to determine whether the enhanced cell death is due to apoptosis. This analysis showed that caspase activity was greatly increased in Daxx-/- T cells compared to wild type T cells after 12 h of TCR activation (left panel, Fig 5A). When T cells were pretreated with the caspase inhibitor z-VAD-fmk, caspase activities in Daxx-/- T cells was reduced to near wild type levels (Right panel, Fig 5A). To determine whether this caspase activity was responsible for the enhanced cell death response in activated Daxx-/- T cells, zVAD treatment of Daxx-/- and Daxx+/+ T cells followed by TCR stimulation was performed. Proliferation and cell death were detected by two-color CellTrace Violet and PI flow cytometry analysis. Similar to the data in Fig 4D, higher percentages of the PI+ population (dying/dead cells) as well as divided populations were observed in activated Daxx-/- T cells than in control Daxx+/+ T cells (right panel, Fig 5B). However, zVAD-treated Daxx-/- T cells had less cell death compared to untreated Daxx-/- T cells after 48 h of TCR activation (60.6% vs. 45.1%, respectively), while faster cell division in activated Daxx-/- T cells was not affected (right panel, Fig 5B). Therefore, caspase activation appears to play some role in enhanced cell death in Daxx-deficient T cells. In further analysis, greatly increased Annexin V+PI- cells were present in Daxx-/- T cells, and caspase inhibitors, zVAD and Q-VD, partially inhibited Daxx-/- T cells death (Fig 5C).
(A), T cells were incubated with or without zVAD and activated with agonistic anti-CD3/CD28 abs for 12 h and caspase activity was measured using CellEvent Caspase-3/7 Green Detection Reagent. (B), T cells were labeled with CellTrace violet, preteated with or without zVAD, and then activated with agonistic anti-CD3/CD28 abs. At 48 h, T cells were collected and stained with PI and analyzed by two-color flow cytometry. Percentages (±SEM, n = 3) of undivided (CellTrace violet+PI-) and divided cells (CellTrace violetloPI-) and cell death (PI+) are indicated. (C), T cells were pretreated for 1 h with the vehicle or indicated caspase inhibitors, and were activated with anti-CD3/CD28 abs for 14 h. T cells were then stained with Annexin V and propidium iodide, and two color flow cytometric analysis was performed.
T cells may undergo apoptosis through the p53-mediated pathway. Previous studies had indicated that Daxx plays a role in regulating posttranslational stability of the p53 tumor suppressor through interaction with the Mdm2/Hausp complex . However, no consistent difference in p53 expression was observed between Daxx-/- and Daxx+/+ T cells (Fig 6A). In vivo survival of Daxx-/- T cells transferred to sublethally irradiated hosts were also greatly diminished compared to Daxx+/+ control T cells (Fig 6B). Significant numbers of T cells were still present in older (6 month) Daxxt-/- mice (Fig 6C), indicating that the T cell deficiency phenotype in young mice (2 month) does not become proportionally more serious as mice age.
(A), T cells were stimulated through CD3 and CD28 for 24 h, and the levels of the indicated proteins were analyzed by western blotting. Numbers indicate fold changes. Ponceau S was used to stain the membrane to visualize proteins transfer. (B.), CD45.2 T cells were adoptively transferred into sublethally irradiated CD45.1 host mice, and T cells in the spleen and lymph nodes were isolated and enumerated 7 days post transfer. (C), T cells numbers in the spleen and lymph nodes of 2-month-old mice were compared with 6-month-old mice (n = 6).
The primary objective of the current study is to address a long-standing enigmatic issue regarding the role of Daxx in Fas-induced apoptosis. To this end, our data showed that conditional deletion of Daxx does not lead to progressive accumulation of T cells in the periphery, a hallmark of the lpr disease in Fas-/- mutant mice. To the contrary, the peripheral T cell pool was decreased upon T cell-specific deletion of Daxx (Figs 1 and 2). Moreover, no defect in Fas-induced apoptosis was detected in Daxx-/- T cells (Fig 3). Although embryonic development was disrupted when Daxx was deleted in germ cells, as shown in the previous study , the thymic T cell population was unaffected when Daxx was deleted after T lineage commitment (Fig 2B). Therefore, while essential in embryonic cells, Daxx is dispensable in thymocyte development. Importantly, the current study reveals a novel function for Daxx in mature T cells survival ex vivo (Figs 4C and 4D and 5A and 5B) as well as in vivo (Fig 6B and 6C). In total, our data indicate a novel mechanistic insight that Daxx suppresses activation-induced cell death in mature T cells.
Regulation of apoptosis plays a critical role in the immune system. Extrinsic cell death through Fas signaling helps maintain immune system homeostasis and suppress autoimmune disease. The challenge in analysis of Daxx function lies, in part, in the essential role for Daxx in early embryonic development, precluding proper studies without viable Daxx-/- mice. Prior studies depended largely on the use of a dominant negative Daxx mutant, which may have unintended effects [20–22]. For example, using the same Daxx-DN mutant, two independent studies reached opposing conclusions regarding the function of Daxx in Fas-induced apoptosis [27,28]. To date, the only other available system is a mouse Daxx-/- embryonic stem cell line, which was used in understanding a Fas-independent function for Daxx in controlling Mdm2 stability . However, a major role for Fas is inducing apoptosis in lymphocytes. The data using a conditional Daxx knockout mouse model demonstrate that Daxx does not play a role in Fas-induced apoptosis in immature T cells, nor in resting or activated mature T cells (Fig 3). By contrast, Daxx deficiency leads to enhanced death in T cells activated through the TCR (Fig 4C–4E).
Although Daxx binds to Fas in yeast cells, the interaction between the endogenous proteins could not readily be detected in mammalian cells [20–22]. In contrast, FADD is readily recruited to Fas in a stimulatory signal-dependent manner and can be detected using conventional co-immunoprecipitation assays [13–15,38]. The DD-containing carboxyl half of FADD functions as a potent dominant negative mutant (FADD-DN), blocking endogenous FADD-Fas interaction and apoptosis induced by stimulation of Fas [13,15]. Interestingly, FADD deficiency blocks embryonic development . Conditional FADD deficiency renders T cells and B cells resistant to Fas-induced apoptosis [32,40]. However, FADD deletion does not lead to the lpr-like lymphocyte accumulative-autoimmune diseases [32,40], as seen in Fas-deficient mice. Similarly, transgenic expression of FADD-DN blocks Fas-induced apoptosis without causing lpr disease [41–43]. This has raised the possibility that Daxx may direct a parallel, FADD-independent, death signal leading from Fas. However, recent studies demonstrated that absence of FADD unleashes a necrotic death, which is dependent on RIP1 and RIP3 [44,45].
Promiscuous interaction of Daxx with many proteins, depending on various in vitro assays used, has been noted previously . Although Daxx-DN could block Fas-induced apoptosis in vitro using various non-lymphoid cell lines [20–22,26,46], further validation using primary Daxx-deficient cells has not been carried out until the current study. Our data show that Fas-induced apoptosis proceeds normally in T cells without Daxx (Fig 3). If there is abnormality in cell death responses, Daxx-deficient T cells die more readily when activated (Fig 4C–4E). Indeed, ex vivo accumulation of activated Daxx-deficient T cells was significantly reduced compared to wild type control T cells (Fig 4E). This may partially explain the reduced T cell pool in the periphery when Daxx is deleted (Figs 1D and 2). Although Daxx is important in mature T cell survival, it appears to play an insignificant role in immature T cells in the thymus (Fig 2B). Although the data show enhanced caspase activation and increased annexin V+PI- population, caspase inhibitors displayed an incomplete effect on death in Daxx-/- T cells (Fig 5). This indicates that apoptosis only plays a partial role in death responses in Daxx-/- T cells. Adoptive transfer experiments indicate increased death in Daxx-/- T cells in vivo (Fig 6B). In the current model, Daxx expression is intact in hematopoietic stem/progenitor (HSC/P) cells, and deletion of Daxx is not induced in the T lineage until development proceeds to immature T cells. Therefore, it is unlikely that the conditional Daxxt-/- mutant mouse would be completely devoid of T cells as they age, given that HSC/P cells are Daxx-sufficient. This is indeed that case, as shown in Fig 6C.
In conclusion, the current study helps clarify that Daxx is dispensable in Fas-induced apoptosis and does not play a role in regulating p53 turnover in T cells. Importantly, the data revealed a novel role for Daxx in maintaining the peripheral mature T cell pool without affecting T cell development in the thymus. Daxx is not only present in cytoplasm but also performs certain functions in the nucleus. Future studies will aim on in-depth understanding of the pathways that Daxx regulates in T cells and additional cell types.
This study is supported in part by NIH grants R21 AI105794 and R01 AI119069 to J.Z. The Flow Cytometry Facility and Research Animal Facility of the Sidney Kimmel Cancer Center, where some of the analysis was performed, is supported in part by NCI Cancer Center support grant P30CA56036. Jinghe Li was a volunteer visiting scholar from The Second Hospital of Jilin University, Changchun, China. The authors thank Drs. Yubo Cai and Zhongjie Shi for the help in preparation of lymphoid cellularity data analysis, Carmen Acosta for technical help, Jennifer Wilson, Eric C. Zhang and Ayhsa Ejaz for critical reading of the manuscript.
- Conceptualization: JZ.
- Data curation: JL LQ JPD CC DK JZ.
- Formal analysis: JL LQ JPD.
- Funding acquisition: JZ.
- Investigation: JL LQ JPD JZ.
- Methodology: JZ.
- Project administration: JZ.
- Supervision: JZ JPD LQ.
- Writing – original draft: JZ.
- Writing – review & editing: JPD LQ JL.
- 1. Strasser A, Jost PJ, Nagata S (2009) The many roles of FAS receptor signaling in the immune system. Immunity 30: 180–192. pmid:19239902
- 2. Watanabe FR, Brannan CI, Itoh N, Yonehara S, Copeland NG, et al. (1992) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148: 1274–1279. pmid:1371136
- 3. Ogasawara J, Watanabe FR, Adachi M, Matsuzawa A, Kasugai T, et al. (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 806–809. pmid:7689176
- 4. Ogasawara J, Suda T, Nagata S (1995) Selective apoptosis of CD4+CD8+ thymocytes by the anti-fas antibody. J Exp Med 181: 485–491. pmid:7530758
- 5. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, et al. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233–243. pmid:1713127
- 6. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, et al. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301–305. pmid:2787530
- 7. Cohen PL, Eisenberg RA (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 9: 243–269.
- 8. Watanabe FR, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314–317. pmid:1372394
- 9. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, et al. (1996) Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 93: 2131–2136. pmid:8700897
- 10. Fukuyama H, Adachi M, Suematsu S, Miwa K, Suda T, et al. (1998) Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice. J Immunol 160: 3805–3811. pmid:9558084
- 11. Itoh N, Nagata S (1993) A novel protein domain required for apoptosis. J Biol Chem 268: 10932–10937. pmid:7684370
- 12. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845–853. pmid:8397073
- 13. Zhang J, Winoto A (1996) A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol Cell Biol 16: 2756–2763. pmid:8649383
- 14. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, et al. (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270: 7795–7798. pmid:7536190
- 15. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505–512. pmid:7538907
- 16. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817–827. pmid:8681377
- 17. Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85: 803–815. pmid:8681376
- 18. Nagata S, Golstein P (1995) The Fas death factor. Science 267: 1449–1455. pmid:7533326
- 19. Nagata S (1997) Apoptosis by death factor. Cell 88: 355–365. pmid:9039262
- 20. Yang X, Khosravi-Far R, Chang HY, Baltimore D (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89: 1067–1076. pmid:9215629
- 21. Chang HY, Yang X, Baltimore D (1999) Dissecting Fas signaling with an altered-specificity death-domain mutant: Requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation. Proceedings of the National Academy of Sciences 96: 1252–1256.
- 22. Chang HY, Nishitoh H, Yang XL, Ichijo H, Baltimore D (1998) Activation of apoptosis signal regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281: 1860–1863. pmid:9743501
- 23. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, et al. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95) associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579–5588. pmid:8521815
- 24. Kim YY, Park BJ, Seo GJ, Lim JY, Lee SM, et al. (2003) Long form of cellular FLICE-inhibitory protein interacts with Daxx and prevents Fas-induced JNK activation. Biochem Biophys Res Commun 312: 426–433. pmid:14637155
- 25. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190–195. pmid:9217161
- 26. Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA (2001) TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 3: 708–714. pmid:11483955
- 27. Villunger A, Huang DC, Holler N, Tschopp J, Strasser A (2000) Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD. J Immunol 165: 1337–1343. pmid:10903735
- 28. Leal-Sanchez J, Couzinet A, Rossin A, Abdel-Sater F, Chakrabandhu K, et al. (2006) Requirement for Daxx in mature T-cell proliferation and activation. Cell Death and Differentiation 14: 795–806. pmid:17082815
- 29. Michaelson JS, Bader D, Kuo F, Kozak C, Leder P (1999) Loss of Daxx, a promiscously interacting protein, results in extensive apoptosis in early mouse development. Genes & Dev 13: 1918–1923.
- 30. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, et al. (2001) A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763–774. pmid:11728338
- 31. Hughes PD, Belz GT, Fortner KA, Budd RC, Strasser A, et al. (2008) Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28: 197–205. pmid:18275830
- 32. Zhang Y, Rosenberg S, Wang H, Imtiyaz HZ, Hou YJ, et al. (2005) Conditional Fas-Associated Death Domain Protein (FADD):GFP Knockout Mice Reveal FADD Is Dispensable in Thymic Development but Essential in Peripheral T Cell Homeostasis. J Immunol 175: 3033–3044. pmid:16116191
- 33. Feng B, Cheng S, Hsia CY, King LB, Monroe JG, et al. (2004) NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival. Cell Immunol 232: 9–20. pmid:15922711
- 34. Dhein J, Walczac H, Baumler C, Dabatin K-M, Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373: 438–441. pmid:7530335
- 35. Brunner T, Mogil R, LaFace D, Yoo NJ, Mahboubi A, et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441–444. pmid:7530336
- 36. Budd RC (2001) Activation-induced cell death. Curr Opin Immunol 13: 356–362. pmid:11406369
- 37. Tang J, Qu LK, Zhang J, Wang W, Michaelson JS, et al. (2006) Critical role for Daxx in regulating Mdm2. Nat Cell Biol 8: 855–862. pmid:16845383
- 38. Imtiyaz HZ, Zhang Y, Zhang J (2005) Structural Requirements for Signal-induced Target Binding of FADD Determined by Functional Reconstitution of FADD Deficiency. J Biol Chem 280: 31360–31367. pmid:16009710
- 39. Zhang J, Cado D, Chen A, Kabra NH, Winoto A (1998) Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392: 296–300. pmid:9521326
- 40. Imtiyaz HZ, Rosenberg S, Zhang Y, Rahman ZS, Hou YJ, et al. (2006) The Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cells. J Immunol 176: 6852–6861. pmid:16709845
- 41. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, et al. (1998) A role for FADD in T cell activation and development. Immunity 8: 439–449. pmid:9586634
- 42. Newton K, Harris AW, Strasser A (2000) FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J 19: 931–941. pmid:10698935
- 43. Hueber AO, Zornig M, Bernard AM, Chautan M, Evan G (2000) A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts. Journal of Biological Chemistry 275: 10453–10462. pmid:10744735
- 44. Zhang H, Zhou X, McQuade T, Li J, Chan FK, et al. (2011) Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471: 373–376. pmid:21368761
- 45. Lu JV, Weist BM, van Raam BJ, Marro BS, Nguyen LV, et al. (2011) Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A.
- 46. Yun HJ, Yoon JH, Lee JK, Noh KT, Yoon KW, et al. (2011) Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling. EMBO J 30: 2465–2476. pmid:21572393